What is the indication for Hydroxyzine (Hydroxyzine) Pamoate 50mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Indications for Hydroxyzine Pamoate 50mg

Hydroxyzine pamoate 50mg is primarily indicated for the treatment of anxiety disorders, particularly generalized anxiety disorder (GAD), as an anxiolytic medication, and as a sedative for insomnia and pre-procedural anxiety.

Primary Indications

Anxiety Disorders

  • Generalized Anxiety Disorder (GAD)
    • Effective at 50mg/day for reducing anxiety symptoms 1
    • Shows significant anxiolytic effects starting from the first week of treatment 2, 3
    • Maintains efficacy throughout treatment periods of up to 12 weeks 1
    • Comparable efficacy to benzodiazepines but without risk of dependency 3, 1

Sleep Disorders

  • Insomnia
    • Used as a sedative for sleep onset and maintenance difficulties 4
    • Considered a weak treatment option for insomnia compared to other medications 5
    • Dosages of 25mg, 50mg, or 100mg at bedtime have been studied 4

Other Clinical Uses

  • Pre-procedural Anxiety

    • Used for anxiolysis before medical procedures 5
    • Particularly useful in pediatric patients undergoing diagnostic procedures 5
  • Allergic Conditions

    • Management of allergic reactions due to its antihistamine properties 6
    • Can be used for milder allergic reactions as an H1 antihistamine 6

Pharmacological Considerations

Mechanism of Action

  • Acts as a first-generation H1 receptor antagonist (antihistamine)
  • Crosses the blood-brain barrier, producing significant sedative effects 6
  • Provides anxiolytic effects through central nervous system depression

Dosing Considerations

  • Standard dose for anxiety: 50mg/day 2, 1
  • For insomnia: 25-100mg at bedtime 4
  • Reduced dosing may be required in:
    • Elderly patients (increased risk of adverse effects) 6
    • Patients with hepatic impairment (typically half the standard dose) 6
    • Patients with renal impairment 6

Adverse Effects and Precautions

Common Side Effects

  • Sedation/drowsiness (most common, typically transient) 2, 7
  • Dry mouth 2
  • Weight gain 2
  • Cognitive impairment 6

Special Populations

  • Elderly: Use with caution due to increased risk of cognitive decline, falls, and anticholinergic effects 6
  • Children: May impair learning and school performance 6
  • Pregnancy: Contraindicated during early pregnancy 6
  • Liver/Kidney Disease: Requires dose adjustments and careful monitoring 6

Clinical Considerations

Advantages

  • No risk of dependency unlike benzodiazepines 3
  • Effective anxiolytic with rapid onset (within first week) 2, 3
  • No withdrawal symptoms or rebound anxiety after discontinuation 2

Limitations

  • Significant sedative effects may limit daytime use 6, 2
  • Second-generation antihistamines are often preferred due to less CNS penetration 6
  • Limited high-quality evidence for long-term use 7

Alternative Treatments

  • For anxiety: SSRIs, SNRIs, or buspirone may be safer alternatives 6
  • For insomnia: Short-acting benzodiazepine receptor agonists or ramelteon 6
  • For allergic conditions: Second-generation antihistamines with less sedation 6

In clinical practice, hydroxyzine pamoate 50mg should be considered when treating patients with anxiety disorders (particularly GAD), insomnia, or pre-procedural anxiety, especially when other first-line treatments are contraindicated or ineffective.

References

Research

Recent clinical trials of hydroxyzine in generalized anxiety disorder.

Acta psychiatrica Scandinavica. Supplementum, 1998

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Allergic Condition Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hydroxyzine for generalised anxiety disorder.

The Cochrane database of systematic reviews, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.